Last analyzed: May 28, 2026 (Q4 FY26)

Roivant Sciences Ltd.

ROIV

Biotechnology

$29.88

Market Cap

$21M

P/E Ratio

-19.023952

Revenue Rank

Rank 2

Margin Rank

No information

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings callsStock ScreenerFilter by P/E, ROE, growth & moreIPO DashboardUpcoming, open & listed IPOsCompare StocksSide-by-side stock comparisonCalculatorsSIP, CAGR, EMI & moreEarnings CalendarUpcoming earnings callsAnalyze PortfolioAI health check for your portfolioBlogMarket insights & guides